Increased Level of Thrombopoietin during Consumptive Coagulopathy

• References

• 1 Kuter DJ. In vivo effects of Mpl ligand administration and emerging clinical applications for the Mpl ligands.. Curr Opin Hematol 1997; 4: 163-70.
• 2 Nagata Y, Shozaki Y, Nagahisa H, Nagasawa T, Abe T, Todokoro K. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.. Thromb Haemost 1997; 77: 808-14.
• 3 Fielder PJ, Hass P, Nagel M, Stefanich E, Widmer R, Bennett GL, Keller GA, deSauvage FJ, Eaton D. Human platelets as a model for the binding and degradation of thrombopoietin.. Blood 1997; 89: 2782-8.
• 4 Mukai HY, Kojima H, Todokoro K, Tahara T, Kato T, Hasegawa Y, Kobayashi T, Ninomiya H, Nagasawa T, Abe T. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura.. Thromb Haemost 1996; 76: 675-8.
• 5 Chang M, Suen Y, Meng G, Buzby JS, Bussel J, Shen V, Ven van de C, Cairo MS. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: Insight into the regulation of platelet production.. Blood 1996; 88: 3354-62.
• 6 Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit.. Blood 1996; 85: 2720-30.